Introduction of a survivin gene-specific small inhibitory RNA inhibits growth of pancreatic cancer cells

Anticancer Research

Volumn 25, Issue 6 B, 2005, Pages 3967-3972

  Tsuji, Naoki ^a   Asanuma, Koichi ^a   Kobayashi, Daisuke ^a   Yagihashi, Atsuhito ^a   Watanabe, Naoki ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Pancreatic cancer cells; Small inhibitory RNA; Survivin

Indexed keywords

FAS LIGAND; MESSENGER RNA; SMALL INTERFERING RNA; SURVIVIN;

APOPTOSIS; ARTICLE; CANCER CELL; CANCER GROWTH; CANCER INHIBITION; CELL CYCLE; CONTROLLED STUDY; DNA DETERMINATION; DRUG SPECIFICITY; DRUG TARGETING; FLOW CYTOMETRY; GENE; HISTOGRAM; HUMAN; HUMAN CELL; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURVIVIN GENE; WESTERN BLOTTING;

CELL GROWTH PROCESSES; CELL LINE, TUMOR; GENE THERAPY; HUMANS; MICROTUBULE-ASSOCIATED PROTEINS; NEOPLASM PROTEINS; PANCREATIC NEOPLASMS; RNA INTERFERENCE; RNA, SMALL INTERFERING; TRANSFECTION;

EID: 27944444428     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Thompson CB: Apoptosis in the pathogenesis and treatment of disease. Science 267: 1456-1462, 1995.
2. Saikumar P, Dong Z, Mikhailov V, Denton M, Weinberg JM and Venkatachalam MA: Apoptosis: definition, mechanisms, and relevance to disease. Am J Med 107: 489-506, 1999.
3. Jaattela M: Escaping cell death: survival proteins in cancer. Exp Cell Res 248: 30-43, 1999.
4. Tanaka K, Iwamoto S, Gon G, Nohara T, Iwamoto M and Tanigawa N: Expression of survivin and its relationship to loss of apoptosis in breast carcinomas. Clin Cancer Res 6: 127-134, 2000.
5. Kato J, Kuwabara Y, Mitani M, Shinoda N, Sato A, Toyama T, Mitsui A, Nishiwaki T, Moriyama S, Kudo J and Fujii Y: Expression of survivin in esophageal cancer: correlation with the prognosis and response to chemotherapy. Int J Cancer 20: 9592-9595, 2001.
6. Lu CD, Altieri DC and Tanigawa N: Expression of a novel antiapoptosis gene, survivin, correlated with tumor cell apoptosis and p53 accumulation in gastric carcinomas. Cancer Res 58: 1808-1812, 1998.
7. Nakamura M, Tsuji N, Asanuma K, Kobayashi D, Yagihashi A, Hirata K, Torigoe T, Sato N and Watanabe N: Survivin as a predictor of cis-diamminedichloroplatinum sensitivity in gastric cancer patients. Cancer Sci 95: 44-51, 2004.
8. Kawasaki H, Altieri DC, Lu CD, Toyoda M, Tenjo T and Tanigawa N: Inhibition of apoptosis by survivin predicts shorter survival rates in colorectal cancer. Cancer Res 58: 5071-5074, 1998.
9. Sarela AI, Macadam RC, Farmery SM, Markham AF and Guillou PJ: Expression of the antiapoptosis gene, survivin, predicts death from recurrent colorectal carcinoma. Gut 46: 645-650, 2000.
10. Satoh K, Kaneko K, Hirota M, Masamune A, Satoh A and Shimosegawa T: Expression of survivin is correlated with cancer cell apoptosis and is involved in the development of human pancreatic duct cell tumors. Cancer 92: 271-278, 2001.
11. Tamm I, Wang Y, Sausville E, Scudiero DA, Vigna N, Oltersdorf T and Reed JC: IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs. Cancer Res 58: 5315-5320, 1998.
12. Asanuma K, Kobayashi D, Furuya D, Tsuji N, Yagihashi A and Watanabe N: A role for survivin in radioresistance of pancreatic cancer cells. Jpn J Cancer Res 93: 1057-1062, 2002.
13. Li F, Ambrosini G, Chu EY, Plescia J, Tognin S, Marchisio PC and Altieri DC: Control of apoptosis and mitotic spindle checkpoint by survivin. Nature 396: 580-584, 1998.
14. Bolton MA, Lan W, Powers SE, McCleland ML, Kuang J and Stukenberg PT: Aurora B kinase exists in a complex with survivin and INCENP and its kinase activity is stimulated by survival binding and phosphorylation. Mol Biol Cell 13: 3064-3077, 2002.
15. Chen J, Jin S, Tahir SK, Zhang H, Liu X, Sarthy AV, McGonigal PT, Liu Z, Rosenberg SH and Ng SC: Survivin enhances aurora-B kinase activity and localizes aurora-B in human cells. J Biol Chem 275: 486-490, 2003
16. Asanuma K, Tsuji N, Endoh T, Yagihashi A and Watanabe N: Survivin enhances Fas ligand expression via up-regulation of Sp1-mediated gene transcription in colon cancer cells. J Immunol 172: 3922-3929, 2004.
17. Harborth J, Elbashir SM, Bechert K, Tuschl T and Weber K: Identification of essential genes in cultured mammalian cells using small interfering RNAs. J Cell Sci 114: 4557-4565, 2001.
18. Dudley NR, Labbe JC and Goldstein B: Using RNA interference to identify genes required for RNA interference. Proc Natl Acad Sci USA 99: 4191-4196, 2002.
19. Caplen NJ, Parrish S, Imani F, Fire A and Morgan RA: Specific inhibition of gene expression by small double-stranded RNAs in invertebrate and vertebrate systems. Proc Natl Acad Sci USA 98: 9742-9747, 2001.
20. Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K and Tuschl T: Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411: 494-498, 2001.
21. Mahotka C, Wenzel M, Springer E, Gabbert HE and Gerharz CD: Survivin-deltaEx3 and survivin-2B: two novel splice variants of the apoptosis inhibitor survivin with different antiapoptotic properties. Cancer Res 59: 6097-6102, 1999.
22. Tsuji N, Kamagata C, Furuya M, Kobayashi D, Yagihashi A, Morita T, Horita S and Watanabe N: Selection of an internal control gene for quantitation of mRNA in colonic tissues. Anticancer Res 22: 4173-4178, 2002.
23. Nicoletti I, Migliorati G, Pagliacci MC, Grignani F and Riccardi C: A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods 139: 271-279, 1991.
24. Shiraki K, Tsuji N, Shioda T, Isselbacher KJ and Takahashi H: Expression of Fas ligand in liver metastasis of human colonic adenocarcinoma. Proc Natl Acad Sci USA 94: 6420-6425, 1997.
25. Olie RA, Simoes-Wust AP, Baumann B, Leech SH, Fabbro D, Stahel RA and Zangemeister-Wittke U: A novel antisense oligonucleotide targeting survivin expression induces apoptosis and sensitizes lung cancer cells to chemotherapy. Cancer Res 60: 2805-2809, 2000.
26. Kappler M, Bache M, Bartel F, Kotzsch M, Panian M, Wurl P, Blumke K, Schmidt H, Meye A and Taubert H: Knockdown of survivin expression by small interfering RNA reduces the clonogenic survival of human sarcoma cell lines independently of p53. Cancer Gene Ther 11: 186-193, 2004.
27. Williams NS, Gaynor RB, Scoggin S, Verma U, Gokaslan T, Simmang C, Fleming J, Tavana D, Frenkel E and Becerra C: Identification and validation of genes involved in the pathogenesis of colorectal cancer using cDNA microarrays and RNA interference. Clin Cancer Res 9: 931-946, 2003.
28. Altieri DC: Validating survivin as a cancer therapeutic target. Nat Rev Cancer 3: 46-54, 2003.
29. O'Connor DS, Grossman D, Plescia J, Li F, Zhang H, Villa A, Tognin S, Marchisio PC and Altieri DC: Regulation of apoptosis at cell division by p34cdc2 phosphorylation of survivin. Proc Natl Acad Sci USA 97: 13103-13107, 2000.
30. Janicke RU, Ng P, Sprengart ML and Porter AG: Caspase-3 is required for alpha-fodrin cleavage but dispensable for cleavage of other death substrates in apoptosis. J Biol Chem 273: 15540-15545, 1998.